Tsukasa Kadota
Overview
Explore the profile of Tsukasa Kadota including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
35
Citations
1403
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Fujita Y, Kadota T, Kaneko R, Hirano Y, Fujimoto S, Watanabe N, et al.
Commun Biol
. 2024 May;
7(1):514.
PMID: 38710749
Acute lung injury (ALI) is characterized by respiratory failure resulting from the disruption of the epithelial and endothelial barriers as well as immune system. In this study, we evaluated the...
2.
Fujita Y, Fujimoto S, Miyamoto A, Kaneko R, Kadota T, Watanabe N, et al.
Am J Respir Cell Mol Biol
. 2023 Feb;
69(1):34-44.
PMID: 36848313
Idiopathic pulmonary fibrosis (IPF) is a progressive aging-related lung disease associated with increased lung cancer risk. Although previous studies have shown that IPF worsens the survival of patients with lung...
3.
Watanabe N, Fujita Y, Nakayama J, Mori Y, Kadota T, Hayashi Y, et al.
Am J Respir Cell Mol Biol
. 2022 Sep;
67(6):708-719.
PMID: 36108172
Phenotypic alterations in the lung epithelium have been widely implicated in chronic obstructive pulmonary disease (COPD) pathogenesis, but the precise mechanisms orchestrating this persistent inflammatory process remain unknown because of...
4.
Furube A, Kadota T, Gochi M, Saito S, Shibata S, Inaki S, et al.
Respir Investig
. 2022 Jul;
60(5):684-693.
PMID: 35871065
Background: Anti-aquaporin-4 (AQP4) antibody is an autoantibody marker often observed in patients with neuromyelitis optica spectrum disorder (NMOSD). The pathological relevance of complicated pulmonary disorders in anti-AQP4 antibody-positive NMOSD remains...
5.
Ito A, Hashimoto M, Tanihata J, Matsubayashi S, Sasaki R, Fujimoto S, et al.
J Cachexia Sarcopenia Muscle
. 2022 Apr;
13(3):1864-1882.
PMID: 35373498
Background: Sarcopenia is characterized by the loss of skeletal muscle mass and strength and is associated with poor prognosis in patients with chronic obstructive pulmonary disease (COPD). Cigarette smoke (CS)...
6.
Kadota T, Fujita Y, Araya J, Ochiya T, Kuwano K
Eur Respir Rev
. 2022 Jan;
31(163).
PMID: 35082125
The unperturbed lung is highly quiescent, with a remarkably low level of cell turnover. However, once damaged, the lung shows an extensive regenerative capacity, with resident progenitor cell populations re-entering...
7.
Takekoshi D, Inukai S, Hatano S, Fujimoto S, Kadota T, Takeda T, et al.
Intern Med
. 2021 Nov;
61(12):1877-1880.
PMID: 34776493
We herein report two cases of cerebrospinal fluid (CSF) rhinorrhea associated with lung infiltrates. One patient presented with symptomatic non-resolving pneumonia, while the other was asymptomatic. In both cases, the...
8.
Kadota T, Fujita Y, Araya J, Watanabe N, Fujimoto S, Kawamoto H, et al.
J Extracell Vesicles
. 2021 Aug;
10(10):e12124.
PMID: 34377373
Idiopathic pulmonary fibrosis (IPF) is characterized by devastating and progressive lung parenchymal fibrosis, resulting in poor patient prognosis. An aberrant recapitulation of developmental lung gene expression, including genes for transforming...
9.
Araya J, Saito N, Hosaka Y, Ichikawa A, Kadota T, Fujita Y, et al.
J Immunol
. 2021 Jun;
207(1):65-76.
PMID: 34135057
Insufficient autophagic degradation has been implicated in accelerated cellular senescence during chronic obstructive pulmonary disease (COPD) pathogenesis. Aging-linked and cigarette smoke (CS)-induced functional deterioration of lysosomes may be associated with...
10.
Fujita Y, Hoshina T, Matsuzaki J, Yoshioka Y, Kadota T, Hosaka Y, et al.
J Extracell Vesicles
. 2021 Jun;
10(8):e12092.
PMID: 34122778
The clinical manifestations of COVID-19 vary broadly, ranging from asymptomatic infection to acute respiratory failure and death. But the predictive biomarkers for characterizing the variability are still lacking. Since emerging...